HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Cosmetic Imports “Enforcement Spike” Serves To Warn Multinationals

This article was originally published in The Rose Sheet

Executive Summary

FDA stepped up its surveillance of cosmetic imports over the summer, subjecting those importing products to the U.S. to increased scrutiny of color additives, labeling and permitted uses.

You may also be interested in...



FDA Adapts Enforcement Strategy In Increasingly Globalized Market

FDA will overhaul its enforcement approach to reflect the impact of globalization by partnering more with foreign counterparts, streamlining inspections, recalls and emergency responses and using stiff criminal sanctions to deter noncompliance, FDA officials say.

FDA Crackdown On Anti-Aging Imports Signals "Major Enforcement Initiative"

Increased scrutiny of anti-aging products entering the U.S. presages "a major enforcement initiative" against illegal cosmetic claims that will impact domestic personal-care firms, large and small, according to attorney and ex-FDAer Benjamin L. England

FDA's PREDICT Makes Accelerated Entry Likely For Most Imports

An FDA information technology system designed to identify high-risk imports for possible inspection - which has been tested with success on food imports - should speed U.S. entry for about 80 percent of FDA-regulated products coming into the country

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017801

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel